ACURA PHARMACEUTICALS, INCACUR
Market cap
P/E ratio
| 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | |
| Stock-based compensation | 2 | 2 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Cash from operations | 12 | -7 | -14 | -11 | -4 | -6 | -5 | -4 | -1 | -1 | -1 |
| Capital expenditures | -0 | 0 | -0 | -0 | -0 | -0 | - | - | - | - | - |
| Cash from investing | -0 | -20 | 6 | -0 | 0 | 11 | 0 | - | - | - | - |
| Proceeds from issuance of term debt, net | - | - | -0 | - | - | - | - | - | - | - | - |
| Cash from financing | -1 | -1 | 12 | -1 | 5 | -3 | 1 | 2 | 1 | 0 | 0 |
| Free cash flow | - | - | - | - | |||||||
| FCF margin (%) | - | - | - | - | - |